InvestSMART

Castile Resources Ltd (ASX: CST) - Announcements

- Current share price for CST : $0.066

ASX company news and announcements for Castile Resources Ltd (CST) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Castile Resources Ltd (CST) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Castile Resources Ltd (CST), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Castile Resources Ltd (CST)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Shareholders approve Scheme of Arrangement 3 Aug 2011 4:20PM $3.770 $0.066 fallen by 98.25%
$25 Trading Halt 3 Aug 2011 8:41AM $3.760 $0.066 fallen by 98.24%
$25 Cellestis Limited Announces Improved Proposal by QIAGEN N.V. 11 Jul 2011 9:15AM $3.760 $0.066 fallen by 98.24%
$25 Financial Guidance for Year Ended 30 June 2011 7 Jul 2011 3:29PM n/a $0.066 n/a
$25 Cellestis shareholders to vote on Scheme proposal 15 Jun 2011 8:29AM $3.350 $0.066 fallen by 98.03%
$25 Cellestis Recommends Proposed Acquisition by Qiagen NV 4 Apr 2011 8:49AM $3.470 $0.066 fallen by 98.10%
$25 Half Yearly Report and Accounts 14 Feb 2011 2:40PM $3.420 $0.066 fallen by 98.07%
$25 AGM Presentation 2010 15 Nov 2010 2:11PM $2.250 $0.066 fallen by 97.07%
$25 Preliminary Final Report 23 Aug 2010 2:57PM $2.680 $0.066 fallen by 97.54%
$25 New CDC Guidelines for use of IGRA (QFT) in the US 25 Jun 2010 9:03AM $2.950 $0.066 fallen by 97.76%
$25 Half Yearly report and Accounts 15 Feb 2010 3:20PM $3.210 $0.066 fallen by 97.94%
$25 QuantiFERON TB Gold In-Tube Approved in Taiwan 5 Feb 2010 12:36PM $3.490 $0.066 fallen by 98.11%
$25 Preliminary Final Report 25 Aug 2009 10:09AM $3.510 $0.066 fallen by 98.12%
$25 QuantiFERON-TB Gold In-Tube Approved in Japan 14 Apr 2009 10:22AM $2.660 $0.066 fallen by 97.52%
$25 Half Yearly Report and Accounts 16 Feb 2009 3:22PM $1.785 $0.066 fallen by 96.30%
$25 Appendix 4C - quarterly 23 Oct 2008 11:00AM $2.010 $0.066 fallen by 96.72%
$25 Preliminary Final Report 25 Aug 2008 2:30PM $2.300 $0.066 fallen by 97.13%
$25 Appendix 4C - quarterly 21 Jul 2008 9:43AM $2.290 $0.066 fallen by 97.12%
$25 2008 Profit Guidance 16 Jun 2008 11:59AM $2.840 $0.066 fallen by 97.68%
$25 Appendix 4C - quarterly 15 Apr 2008 9:18AM $2.270 $0.066 fallen by 97.09%
$25 Half Yearly Report and Accounts 19 Feb 2008 9:30AM $2.130 $0.066 fallen by 96.90%
$25 QFT proven six times more effective for TB control 15 Feb 2008 11:10AM $2.750 $0.066 fallen by 97.60%
$25 Appendix 4C - Quarterly 23 Jan 2008 5:01PM $2.290 $0.066 fallen by 97.12%
$25 QuantiFERON TB Gold In-Tube Approved in Republic of Korea 17 Dec 2007 2:43PM $3.050 $0.066 fallen by 97.84%
$25 Commitments Test Entity - First Quarter Report 23 Oct 2007 11:18AM $2.840 $0.066 fallen by 97.68%

326 - 350 of 376 results

Page 14 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.